FireFlex-RespiratoryTM
FireFlex-RespiratoryTM
Expands on FireFlex-COVIDTM to to include other respiratory viruses

 

  • Includes influenza A and B, RSV, COVID-19, and COVID-19 variants
  • Option to distinguish flu A from flu B, and distinguish COVID variants
  • Option to identify virus classes: (a) any flu, (b) any COVID, (c) any other
  • Firebird’s technology allows kit to be expanded as new strains emerge




FireFlex-Respiratory

Product specifications

  • Samples: nasal and nasopharyngeal swabs, saliva
  • Sensitivity: < 200 copies of virus per mL
  • Equipment: most 4-channel PCR instruments
  • Sample preparation: From saliva, none
  • Targets: COVID-19, COVID-19 variants, influenza A and B, RSV
  • Signal generation: < 90 minutes

Commercial

  • Firebird makes primers/probes
  • Firebird ships these worldwide for local assembly
  • Enzymes can be sourced locally or from Firebird
  • Partnerships sought worldwide

Technology & Publications

  • Powered by SAMRSTM chemistry
  • Powered by AEGISTM chemistry

Yang & Benner (2020) Compositions for the Multiplexed Detection of Viruses. US Patent Appl. No. 17101467

Related Products

A new test in our family of FireFlexTM products. See also: